Collegium Pharmaceutical, Inc. (COLL) vs Harrow, Inc. (HROW)
- Collegium Pharmaceutical, Inc. COLL 23.19 +0.04%
- Harrow, Inc. HROW 27.28 −5.11%
Collegium Pharmaceutical, Inc. and Harrow, Inc. are both Drug Manufacturers Specialty & Generic companies. Harrow, Inc. is the larger, with a market value of $1.1B against $754.6M — 1.4× the size. Harrow, Inc. has negative trailing earnings, so its P/E is not meaningful; Collegium Pharmaceutical, Inc. trades at 15.2×. Harrow, Inc. grew revenue faster over the last twelve months: 21.1% against 14.3%. Collegium Pharmaceutical, Inc. has the higher net margin (5.93% vs −13.5%) and the higher return on invested capital (7.85% vs −0.77%). Across the 20 metrics below, Collegium Pharmaceutical, Inc. leads on 14 and Harrow, Inc. on 6.
Valuation
Profitability
| Metric | COLL | HROW | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 60.02% | 73.28% | 53.94% |
| Operating margin | 19.48% | (1.00%) | 0.00% |
| Net margin | 5.93% | (13.51%) | 0.00% |
| Free cash flow margin | 40.62% | (4.75%) | 0.00% |
| Return on equity | 17.61% | (116.07%) | (0.40%) |
| Return on assets | 2.57% | (9.77%) | (3.32%) |
| Return on invested capital | 7.85% | (0.77%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack